Compare · CI vs NEUE
CI vs NEUE
Side-by-side comparison of The Cigna Group (CI) and NeueHealth Inc. (NEUE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CI and NEUE operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI carries a market cap of $78.26B.
- CI has hit the wire 5 times in the past 4 weeks while NEUE has been quiet.
- CI has more recent analyst coverage (25 ratings vs 0 for NEUE).
- Company
- The Cigna Group
- NeueHealth Inc.
- Price
- -
- -
- Market cap
- $78.26B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest CI
- The Cigna Group Announces Appearance at the 2026 UBS Global Healthcare Conference
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong Third Quarter 2026 Results, Raises 2026 Outlook
- The Cigna Group Declares Quarterly Dividend
- SEC Form 8-K filed by The Cigna Group
- The Cigna Group's Third Quarter 2026 Earnings Release Details
- Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
- The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities
Latest NEUE
- Chief Financial Officer Matushak Jay returned 40,431 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 15-12G filed by NeueHealth Inc.
- Large owner Bessemer Venture Partners Ix L.P. returned 999,218 shares to the company (SEC Form 4)
- Director Kraus Stephen returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)
- GC & Corporate Secretary Craig Jeffery Michael returned 20,103 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP, Consumer Care Orozco Tomas returned 29,325 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Sheehy Robert J returned 265,945 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Adkins Kedrick D Jr returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Kadre Manuel returned 33,505 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Slavitt Andrew M returned 107,809 shares to the company, closing all direct ownership in the company (SEC Form 4)